Latest stock market podcasts

Between the BellsThe Bellcast
Between the Bells

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Morning Bell 14 October

Bell Direct
October 14, 2025

Morning Bell 13 October

Bell Direct
October 13, 2025

Weekly Wrap 10 October

Bell Direct
October 10, 2025

Morning Bell 9 October

Bell Direct
October 9, 2025

Morning Bell 8 October

Bell Direct
October 8, 2025

Morning Bell 7 October

Bell Direct
October 7, 2025

Weekly Wrap 3 October

Bell Direct
October 3, 2025

Morning Bell 2 October

Bell Direct
October 2, 2025

From the helm: Bhagwan Marine Limited (ASX:BWN), Andrew Wackett, Director of Finance

Bell Direct
October 1, 2025

From the helm: Argenica Therapeutics (ASX:AGN), Dr. Liz Dallimore, CEO & MD

Bell Direct
October 1, 2025

From the helm: Cobram Estate Olives (ASX:CBO), Sam Beaton, Co-CEO

Bell Direct
October 1, 2025

From the helm: Cash Converters (ASX:CCV), Sam Budiselik, CEO & MD

Bell Direct
October 1, 2025
  1. Pages:
  3. 1
  4. ...
  5. 6
  6. 7
  7. 8
  8. 9
  9. 10
  10. 11
  11. 12
  12. ...
  13. 147